- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
High return on equity, past performance and sound balance sheet.
4 companies
ChemoMetec
Market Cap: DKK 11.9b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 683.00
7D
-0.9%
1Y
35.0%
Genmab
Market Cap: DKK 123.8b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,010.00
7D
-3.4%
1Y
28.1%
Gubra
Market Cap: DKK 8.7b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 533.00
7D
1.8%
1Y
-13.2%
Zealand Pharma
Market Cap: DKK 31.5b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 447.40
7D
-7.5%
1Y
-36.5%